drugset / Trial / NCT00191035
Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of atomoxetine administered once daily in the treatment of adolescents with ADHD after 8 weeks and after 52 weeks
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 0.8 mg/kg | — |
| Subject | Atomoxetine | Other / unclassified | 1.4 mg/kg | — |